On day 1, clinical laboratory results showed an elevated white blood cell count (WBC 8,220/μL), anemia (hemoglobin 7.2 g/dL), liver dysfunction (alanine aminotransferase [ALT] 139 U/L, aspartate aminotransferase [AST] 116 U/L, and alkaline phosphatase 176 U/L), and elevated inflammatory markers (C-reactive protein [CRP] 5.75 mg/dL). This evidence concerns the gene GPT and anemia.